Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 75, Issue 10, pp. 1944-1948
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 9, 2014
- Revision received January 28, 2015
- Accepted February 16, 2015
- Published first March 25, 2015.
Article Versions
- Previous version (March 25, 2015 - 14:16).
- Previous version (April 30, 2015 - 13:16).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Chen-Lin Hsieh1,
- Ginevra Botta1,3,
- Shuai Gao4,
- Tiantian Li1,
- Eliezer M. Van Allen1,2,
- Daniel J. Treacy1,
- Changmeng Cai4,
- Housheng Hansen He5,6,
- Christopher J. Sweeney1,
- Myles Brown1,2,
- Steven P. Balk4,
- Peter S. Nelson7,
- Levi A. Garraway1,3,*, and
- Philip W. Kantoff1,*
- Department of 1Medical Oncology, and
- 2Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
- 3Broad Institute, Cambridge, Massachusetts.
- 4Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
- 5Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
- 6Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- 7Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
- ↵*Corresponding Authors:
Philip W. Kantoff, Dana-Farber Cancer Institute, Suite D1230, 450 Brookline Avenue, Boston, MA 02215. Phone: 617-632-1914; Fax: 1-617-632-2165; E-mail: philip_kantoff{at}dfci.harvard.edu; or Levi A. Garraway, levi_garraway{at}dfci.harvard.edu
C.-L. Hsieh and G. Botta contributed equally to this article.
May 2015
Volume 75, Issue 10
Volume 75, Issue 10
PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy
Jump to section
Advertisement